Stacy Raviv1, Lewis J Smith. 1. Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Abstract
PURPOSE OF REVIEW: The goal of this review is to assess recent additions to the medical literature that contribute to the clinical question: 'How might diet act as a disease modifier in patients with asthma?' In vitro, animal, and epidemiologic data are presented as justification for interventional studies, which form the basis of clinical recommendations and decision-making. RECENT FINDINGS: A number of studies suggest roles for n-3 fatty acids, soy isoflavones, vitamin D, and antioxidants as modifiers of asthma severity. However, these studies are generally complicated by small sample sizes and either negative results or findings that are of questionable clinical significance. SUMMARY: The available literature regarding dietary manipulation as asthma therapy is largely unconvincing. Although mechanistic and epidemiologic studies provide a rationale for diet therapies, there are few interventional studies with positive, clinically relevant endpoints. Future studies must include sufficient numbers of well selected patients and measure effects on exacerbations, symptoms, lung function, and medication use.
PURPOSE OF REVIEW: The goal of this review is to assess recent additions to the medical literature that contribute to the clinical question: 'How might diet act as a disease modifier in patients with asthma?' In vitro, animal, and epidemiologic data are presented as justification for interventional studies, which form the basis of clinical recommendations and decision-making. RECENT FINDINGS: A number of studies suggest roles for n-3 fatty acids, soy isoflavones, vitamin D, and antioxidants as modifiers of asthma severity. However, these studies are generally complicated by small sample sizes and either negative results or findings that are of questionable clinical significance. SUMMARY: The available literature regarding dietary manipulation as asthma therapy is largely unconvincing. Although mechanistic and epidemiologic studies provide a rationale for diet therapies, there are few interventional studies with positive, clinically relevant endpoints. Future studies must include sufficient numbers of well selected patients and measure effects on exacerbations, symptoms, lung function, and medication use.
Authors: Jingjing Li; Pengcheng Xun; Daisy Zamora; Akshay Sood; Kiang Liu; Martha Daviglus; Carlos Iribarren; David Jacobs; James M Shikany; Ka He Journal: Am J Clin Nutr Date: 2012-11-28 Impact factor: 7.045
Authors: Lewis J Smith; Ravi Kalhan; Robert A Wise; Elizabeth A Sugar; John J Lima; Charles G Irvin; Allen J Dozor; Janet T Holbrook Journal: JAMA Date: 2015-05-26 Impact factor: 56.272
Authors: Seong H Cho; Ara Jo; Thomas Casale; Su J Jeong; Seung-Jae Hong; Joong K Cho; Janet T Holbrook; Rajesh Kumar; Lewis J Smith Journal: J Allergy Clin Immunol Date: 2019-01-29 Impact factor: 10.793
Authors: Gertrud U Schuster; Jennifer M Bratt; Xiaowen Jiang; Theresa L Pedersen; Dmitry Grapov; Yuriko Adkins; Darshan S Kelley; John W Newman; Nicholas J Kenyon; Charles B Stephensen Journal: Am J Respir Cell Mol Biol Date: 2014-03 Impact factor: 6.914